Yahoo Finance Results
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston ScientificZacks via Yahoo FinanceFeb 28 13:31 PM
Feb 28, 2018 – Today, Zacks Equity Research discusses the Industry: Medical Devices, Part 1, including Johnson & Johnson JNJ, Medtronic MDT, Covidien and Smith & Nephew SNN, Abbott ...
- Bloomberg via Yahoo Finance1 day ago
- Motley Fool via Yahoo Finance1 day ago
- BBC News1 day ago
- Markit via Yahoo FinanceMar 08 13:00 PM
This could indicate that investors who seek to profit from falling equity prices are not currently targeting JNJ. Over the last one-month, outflows of investor capital in ETFs holding JNJ totaled ...
- Benzinga via Yahoo FinanceMar 01 12:30 PM
Cramer would start building a long position in Johnson & Johnson (NYSE: JNJ), but he would do it slowly on its way down and in pyramid fashion.
- ALM Media via Yahoo FinanceMar 09 10:45 AM
After two weeks of trial, the nine-person jury in U.S. District Court for the Northern District of Indiana on Friday rendered its verdict against J&J and its subsidiary, Ethicon, for the manufacture ...
- Motley Fool via Yahoo FinanceMar 19 16:20 PM
Geron's collaboration partner, Johnson & Johnson (NYSE: JNJ), recently completed its third internal data review of the two-arm study with high-risk myelofibrosis patients. Johnson ...
- Benzinga via Yahoo FinanceMar 06 14:38 PM
Vertical Group analyst Gordon Johnson initiated coverage on Trinity Industries with a Sell rating and $20 price target. Trinity is up nearly 25 percent year-over-year, but Johnson ...
- Motley Fool via Yahoo FinanceMar 08 11:37 AM
The best dividend stocks can provide steady income -- often with regular increases -- while also appreciating in value over the long term.
- Motley Fool via Yahoo FinanceFeb 28 2:09 AM
The three dividend stocks that are practically minting money are Apple (NASDAQ: AAPL), Johnson & Johnson (NYSE: JNJ), and Wells Fargo (NYSE: WFC). Together, the three giants generate ...
- Motley Fool via Yahoo FinanceFeb 27 14:06 PM
We might be in the middle of the first quarter, but AbbVie Inc. (NYSE: ABBV) has already delivered enough good news for a whole year. Rheumatoid arthritis, Crohn's disease, and eczema affect ...
- Motley Fool via Yahoo FinanceMar 05 13:18 PM
Here's why AbbVie (NYSE: ABBV) is my top stock to buy in March. AbbVie stock is up more than 80% over the past 12 months and more than 15% so far this year.
- related to Johnson & Johnson